2026. Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. Nigerian Journal of Physiological Sciences. 40, 2 (abr. 2026). DOI:https://doi.org/10.54548/.